These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 33573232)

  • 1. Preclinical Evaluation of
    Abouzayed A; Rinne SS; Sabahnoo H; Sörensen J; Chernov V; Tolmachev V; Orlova A
    Pharmaceutics; 2021 Jan; 13(2):. PubMed ID: 33573232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I Trial of [
    Chernov V; Rybina A; Zelchan R; Medvedeva A; Bragina O; Lushnikova N; Doroshenko A; Usynin E; Tashireva L; Vtorushin S; Abouzayed A; Rinne SS; Sörensen J; Tolmachev V; Orlova A
    Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The GRPR Antagonist [
    Abouzayed A; Borin J; Lundmark F; Rybina A; Hober S; Zelchan R; Tolmachev V; Chernov V; Orlova A
    Diagnostics (Basel); 2023 May; 13(9):. PubMed ID: 37175001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical Evaluation of the Copper-64 Labeled GRPR-Antagonist RM26 in Comparison with the Cobalt-55 Labeled Counterpart for PET-Imaging of Prostate Cancer.
    Baun C; Mitran B; Rinne SS; Dam JH; Olsen BB; Tolmachev V; Orlova A; Thisgaard H
    Molecules; 2020 Dec; 25(24):. PubMed ID: 33352838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical Characterization of a Stabilized Gastrin-Releasing Peptide Receptor Antagonist for Targeted Cancer Theranostics.
    Abouzayed A; Kanellopoulos P; Gorislav A; Tolmachev V; Maina T; Nock BA; Orlova A
    Biomolecules; 2023 Jul; 13(7):. PubMed ID: 37509170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and characterization of a high-affinity NOTA-conjugated bombesin antagonist for GRPR-targeted tumor imaging.
    Varasteh Z; Velikyan I; Lindeberg G; Sörensen J; Larhed M; Sandström M; Selvaraju RK; Malmberg J; Tolmachev V; Orlova A
    Bioconjug Chem; 2013 Jul; 24(7):1144-53. PubMed ID: 23763444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selection of optimal chelator improves the contrast of GRPR imaging using bombesin analogue RM26.
    Mitran B; Varasteh Z; Selvaraju RK; Lindeberg G; Sörensen J; Larhed M; Tolmachev V; Rosenström U; Orlova A
    Int J Oncol; 2016 May; 48(5):2124-34. PubMed ID: 26983776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and Preclinical Evaluation of
    Makris G; Bandari RP; Kuchuk M; Jurisson SS; Smith CJ; Hennkens HM
    Mol Imaging Biol; 2021 Feb; 23(1):52-61. PubMed ID: 32886303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of macrocyclic chelators on the targeting properties of the 68Ga-labeled gastrin releasing peptide receptor antagonist PEG2-RM26.
    Varasteh Z; Mitran B; Rosenström U; Velikyan I; Rosestedt M; Lindeberg G; Sörensen J; Larhed M; Tolmachev V; Orlova A
    Nucl Med Biol; 2015 May; 42(5):446-454. PubMed ID: 25684649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two Novel [
    Kanellopoulos P; Bezverkhniaia E; Abouzayed A; Rosenström U; Tolmachev V; Orlova A
    ACS Omega; 2024 Apr; 9(16):18608-18616. PubMed ID: 38680331
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Rinne SS; Abouzayed A; Gagnon K; Tolmachev V; Orlova A
    Sci Rep; 2021 Feb; 11(1):3631. PubMed ID: 33574368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positron Emission Tomography Imaging of Prostate Cancer with Ga-68-Labeled Gastrin-Releasing Peptide Receptor Agonist BBN
    Cheng S; Lang L; Wang Z; Jacobson O; Yung B; Zhu G; Gu D; Ma Y; Zhu X; Niu G; Chen X
    Bioconjug Chem; 2018 Feb; 29(2):410-419. PubMed ID: 29254329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo evaluation of a (18)F-labeled high affinity NOTA conjugated bombesin antagonist as a PET ligand for GRPR-targeted tumor imaging.
    Varasteh Z; Aberg O; Velikyan I; Lindeberg G; Sörensen J; Larhed M; Antoni G; Sandström M; Tolmachev V; Orlova A
    PLoS One; 2013; 8(12):e81932. PubMed ID: 24312607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GRPR-Antagonists Carrying DOTAGA-Chelator via Positively Charged Linkers: Perspectives for Prostate Cancer Theranostics.
    Obeid K; Kanellopoulos P; Abouzayed A; Mattsson A; Tolmachev V; Nock BA; Maina T; Orlova A
    Pharmaceutics; 2024 Apr; 16(4):. PubMed ID: 38675174
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.